Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies.
Experimental vaccines, which independently achieve 48% and 68% reductions in malaria cases, can achieve 91% reduction when combined.
Presently, each vaccine is at a different stage of human trials, and there have not been efforts to combine them. However, a team led by Imperial College London have now tested the effectiveness when using the two types of vaccine together.
Reaching a potential 91% reduction in cases would have a huge impact on public health because the vaccines could be effective in areas where malaria is more prevalent.Dr Andrew Blagborough
The study, published today in the journal eLife, used genetically altered mouse parasites that express proteins expressed on the human version of the malaria parasite. The research was funded by the PATH’s Malaria Vaccine Initiative and the Medical Research Council (MRC), including researchers at Imperial’s MRC Centre for Outbreak Analysis and Modelling.
Lead researcher Dr Andrew Blagborough, from the Department of Life Sciences at Imperial, said: “This is the first direct evidence than combining vaccines of different types significantly improves their efficacy in terms of reducing malarial burden.
“Reaching a potential 91% reduction in cases would have a huge impact on public health because the vaccines could be effective in areas where malaria is more prevalent.”
Two types of vaccines
Malaria is caused by a group of parasites that have a complex life cycle, spending time in the mosquito midgut and salivary glands, in the human liver, and circulating in human blood, where they cause the disease.
The team tested two types of vaccines: those that prevent mosquitoes from transferring the parasites, called transmission-blocking vaccines (TBVs), and those that prevent the parasite from infecting the liver, termed pre-erythrocytic vaccines (PEVs).
RTS,S is the world’s first PEV malaria vaccine that has been shown to provide partial protection against malaria in young children by blocking infection of the liver. However, its maximum efficacy is under 50% (i.e. it reduces cases by around 50%).
There are currently several types of transmission-blocking vaccines in early trials, which are thought to reduce the number of parasites in the mosquito salivary glands. Their efficacy typically ranges from around 50-95%.
It has been assumed that combining these vaccines would increase their efficacy, but it has never been tested until now. The team found that when a partially effective PEV was combined with the most effective transmission-blocking vaccine, the efficacy was around 91%.
The team also found that combining any of the two types of vaccines improved efficacy of the mixture more than might be expected from the single efficacy of each vaccine separately.
Working towards elimination
Dr Morven Roberts, Programme Manager for parasites and neglected tropical diseases at the MRC, said: “While these findings are in the preliminary stages, they’re valuable as they shed light on optimising strategies for preventing malaria. Learning that combining vaccines can dramatically boost efficacy in mice provides another potential tactic for controlling this disease. This is timely research as global health officials work towards WHO targets to eliminate malaria by 2030.”
The team will next study how combined vaccines could work in more complex situations. Dr Blagborough said: “In the real world, the vaccine coverage we can achieve– how many people we can give it to – is important, as are the local levels of transmission, and how prevalent malaria currently is in that area.
“We plan to use a combination of rodent experiments and computer modelling to help us estimate effectiveness requirements for future vaccines.”
The efficacy of current lead malaria vaccines is known to reduce over time after vaccines are administered, so the team will also investigate how combined vaccines perform in the long term.
The Latest on: Malaria
via Google News
The Latest on: Malaria
- Pigi County hit by drug shortages amidst surge in malaria caseson August 25, 2021 at 1:02 am
Pigi County in Jonglei is facing a severe shortage of life-saving drugs amidst a surge in malaria and pneumonia cases due to the floods.
- Malaria Threat Resurfaces Due to Climate Change and Covid-19on August 24, 2021 at 11:59 pm
Indonesia is accountable for 21 percent of South-East Asia region’s malaria cases and 16 percent of malaria deaths.
- Nigeria will be declared malaria free - Health Minister Ehanireon August 24, 2021 at 11:37 pm
Ehanire, stated this at the SuNMaP 2 dissemination meeting, on Tuesday in Abuja, adding that Nigeria will soon be declared malaria-free, like China. SuNMaP 2 is a U.K. aid-funded follow-up to SuNMaP ...
- Malaria vaccine development—where are we?on August 24, 2021 at 10:43 pm
A study published in Nature on June 30 described the latest results for a malaria vaccine candidate based on Sanaria's PfSPZ platform. Priya Venkatesan reports.
- Malaria: FG to focus on lessons from SuNMaP 2on August 24, 2021 at 7:53 pm
The Federal Ministry of Health (FMoH) says it will focus on the lessons learnt from the just concluded Support to National Malaria Programme Phase 11 (SuNMaP 2), to eliminate malaria in the country.
- No malaria, only five dengue cases in Panchkula so far this yearon August 24, 2021 at 7:18 pm
The Health Department, along with the local Municipal Corporation, is carrying out active surveillance and taking preventive steps to keep a check on the vector-borne diseases in the district.
- Monoclonal antibody prevents malaria in early trialon August 24, 2021 at 8:58 am
A monoclonal antibody prevented malaria in people for up to 36 weeks in a Phase 1 clinical trial. Such antibodies could have a variety of uses for travelers, military personnel, health care workers, ...
- Addressing the hidden burden of Malaria-Critical considerations for Malaria eliminationon August 24, 2021 at 5:19 am
Department of Health and Family Welfare, Government of Odisha & Dr Kaushik Sarkar, Interim Country Director, Malaria No More talks about hidden burden of Malaria and way forward ...
- China's successful elimination of malaria, and its global impacton August 19, 2021 at 9:54 pm
China’s achievement shows us that it’s possible to eliminate the disease worldwide. Innovative Chinese approaches may provide a successful formula for Africa, which has 90% of the global malaria ...
via Bing News